November 21, 2023

Cell-Easy and Toulouse University Hospital obtain IMPD approval for first-in-human clinical trial in systemic sclerosis, using promising allogeneic approach

EU regulatory approval to administer Adipose-derived mesenchymal Stem Cells (ASCs) in patients with ischemic digital ulcers marks key milestone for partners Toulouse, France, November 16, 2023 – Cell-Easy, a French Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies, and the Toulouse University Hospital, today announce that they

+ Read More

your CDMO Partner for Cell Therapy

Keep in touch
Linkedin

Cell-Easy

4 Bis avenue Hubert Curien

31100 Toulouse,

FRANCE

Science-driven CDMO specialized in Cell Therapy, Cell-Easy offers customized process development, GMP manufacturing and analytical services for immune cells and adult stem cells in Immuno-oncology and Regenerative Medicine fields.

Privay Policy